ATE73452T1 - Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen. - Google Patents

Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen.

Info

Publication number
ATE73452T1
ATE73452T1 AT86305672T AT86305672T ATE73452T1 AT E73452 T1 ATE73452 T1 AT E73452T1 AT 86305672 T AT86305672 T AT 86305672T AT 86305672 T AT86305672 T AT 86305672T AT E73452 T1 ATE73452 T1 AT E73452T1
Authority
AT
Austria
Prior art keywords
sub
sup
hydrogen atom
alkyl
cycloalkyl
Prior art date
Application number
AT86305672T
Other languages
English (en)
Inventor
Neil Godfrey
Ian H Coats
James A Bell
David C Humber
George B Ewan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE73452T1 publication Critical patent/ATE73452T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
AT86305672T 1985-07-24 1986-07-23 Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen. ATE73452T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858518742A GB8518742D0 (en) 1985-07-24 1985-07-24 Process
EP86305672A EP0221629B1 (de) 1985-07-24 1986-07-23 Verfahren zur Herstellung von 3-Imidazolylmethyltetrahydrocarbazolonen

Publications (1)

Publication Number Publication Date
ATE73452T1 true ATE73452T1 (de) 1992-03-15

Family

ID=10582814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86305672T ATE73452T1 (de) 1985-07-24 1986-07-23 Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen.

Country Status (12)

Country Link
US (1) US4957609A (de)
EP (1) EP0221629B1 (de)
JP (1) JPS6277381A (de)
KR (1) KR920001671B1 (de)
AT (1) ATE73452T1 (de)
CA (1) CA1281721C (de)
DE (1) DE3684235D1 (de)
ES (1) ES2000936A6 (de)
FI (1) FI84351C (de)
GB (1) GB8518742D0 (de)
GR (1) GR861927B (de)
PT (1) PT83044B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
US4939144A (en) * 1987-10-22 1990-07-03 Glaxo Group Limited Tricyclic ketone derivatives as 5-HT antagonists
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
IE63043B1 (en) * 1988-04-13 1995-03-22 Ici America Inc Cyclic amides
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
IL155644A0 (en) * 2000-10-30 2003-11-23 Teva Pharma Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
CA2483566A1 (en) * 2002-04-29 2003-11-13 Biogal Gyogyszergyar Rt. Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
DE602006013688D1 (de) * 2005-11-16 2010-05-27 Hoffmann La Roche Neues verfahren zur herstellung von thoc
EP2470503B1 (de) * 2009-08-24 2014-03-12 Keki Hormusji Gharda Verfahren zur synthese von n-alkyl-carbazol und derivaten davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579132B2 (en) * 1984-01-25 1988-11-17 Glaxo Group Limited Heterocyclic compounds
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones

Also Published As

Publication number Publication date
GR861927B (en) 1986-09-05
FI863020L (fi) 1987-01-25
GB8518742D0 (en) 1985-08-29
FI84351C (fi) 1991-11-25
FI84351B (fi) 1991-08-15
PT83044A (en) 1986-08-01
FI863020A0 (fi) 1986-07-23
KR920001671B1 (ko) 1992-02-22
EP0221629A1 (de) 1987-05-13
JPS6277381A (ja) 1987-04-09
KR870001199A (ko) 1987-03-12
US4957609A (en) 1990-09-18
CA1281721C (en) 1991-03-19
ES2000936A6 (es) 1988-04-01
EP0221629B1 (de) 1992-03-11
PT83044B (pt) 1989-02-28
DE3684235D1 (de) 1992-04-16

Similar Documents

Publication Publication Date Title
ATE73451T1 (de) Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen.
ATE73452T1 (de) Verfahren zur herstellung von 3imidazolylmethyltetrahydrocarbazolonen.
ATE33494T1 (de) 1,8-naphthyridinderivate und verfahren zu ihrer herstellung.
ATE126219T1 (de) Benzimidazolderivate, verfahren zu deren herstellung und anwendung.
DE3854454D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung.
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
ATE246676T1 (de) Tetrahydrochinolinderivate mit selektive aktivität für retinoid x rezeptoren
IE881927L (en) Anellated indole derivatives
ATE57919T1 (de) Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide.
KR840009310A (ko) 디벤조디아제핀 유도체의 제조방법
DE69828284D1 (de) Naphthyridinderivate oder salze davon
EP0371805A3 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
EP0327307A3 (de) Tricyclische Ketonderivate mit 5-HT3 antagonistischer Wirkung
DE69324854D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
DE3872722D1 (de) Indol-derivate.
ATE97404T1 (de) Prostazyklin-(pgi2)-analoge.
DE69427541D1 (de) Verfahren zur Herstellung von Sulfonylharnstoffderivaten
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
DE68922287D1 (de) Imidazol und Pyridyl-Derivate von Phenyl substituierten 1,4-Dihydropyridinen und Verfahren zu ihrer Herstellung.
ATE107657T1 (de) Verfahren zur herstellung von zwischenprodukten für 11-beta,16-alpha,17-alpha,21- tetrahydroxypregna-3-20-dione 16-alpha,17-alpha- acetal und deren 21-ester.
ATE232884T1 (de) Verfahren zur herstellung von kondensationsverbindungen
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
DE3680807D1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time